title: Progress toward measles elimination—Philippines, 1998-2014.
abstract: In 2005, the Regional Committee for the World Health Organization (WHO) Western Pacific Region (WPR) established a goal to eliminate measles by 2012.The recommended elimination strategies in WPR include 1) ≥95% 2-dose coverage with measles-containing vaccine (MCV) through routine immunization services and supplementary immunization activities (SIAs); 2) high-quality case-based measles surveillance; 3) laboratory surveillance with timely and accurate testing of specimens to confirm or discard suspected cases and detect measles virus genotypes; and 4) measles outbreak preparedness, rapid response, and appropriate case management. In the WPR, the Philippines set a national goal in 1998 to eliminate measles by 2008. This report describes progress toward measles elimination in the Philippines during 1998-2014 and challenges remaining to achieve the goal. WHO-United Nations Children's Fund (UNICEF)-estimated coverage with the routine first dose of MCV (MCV1) increased from 80% in 1998 to 90% in 2013, and coverage with the routine second dose of MCV (MCV2) increased from 10% after nationwide introduction in 2010 to 53% in 2013. After nationwide SIAs in 1998 and 2004, historic lows in the numbers and incidence of reported measles cases occurred in 2006. Despite nationwide SIAs in 2007 and 2011, the number of reported cases and incidence generally increased during 2007-2012, and large measles outbreaks occurred during 2013-2014 that affected infants, young children, older children, and young adults and that were prolonged by delayed and geographically limited outbreak response immunization activities during 2013-2014. For the goal of measles elimination in WPR to be achieved, sustained investments are required in the Philippines to strengthen health systems, implement the recommended elimination strategies, and develop additional strategies to identify and reduce measles susceptibility in specific geographic areas and older age groups.
authors: Yoshihiro
authors: Y
authors: Takashima
authors: W William
authors: WW
authors: Schluter
authors: Kayla Mae L
authors: KM
authors: Mariano
authors: Sergey
authors: S
authors: Diorditsa
authors: Maricel
authors: M
authors: de Quiroz Castro
authors: Alan C
authors: AC
authors: Ou
authors: Maria Joyce U
authors: MJ
authors: Ducusin
authors: Luzviminda C
authors: LC
authors: Garcia
authors: Dulce C
authors: DC
authors: Elfa
authors: Alya
authors: A
authors: Dabbagh
authors: Paul
authors: P
authors: Rota
authors: James L
authors: JL
authors: Goodson
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D060740:Disease Eradication; D005838:Genotype; D006801:Humans; D017589:Immunization Programs; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D008457:Measles / Q000453:epidemiology / Q000517:prevention & control*; D008458:Measles Vaccine / Q000008:administration & dosage*; D008459:Measles virus / Q000235:genetics; D010679:Philippines / Q000453:epidemiology; D011159:Population Surveillance; D055815:Young Adult
chemical_list: D008458:Measles Vaccine